Our vision for Veralize includes the capability to perform multi-analyte detection for a wide array of organisms, ensuring a comprehensive approach to biodefense and infection control. We are committed to advancing our technology to simultaneously identify and monitor various biological agents, empowering users with a versatile tool for rapid response and protection in an ever-evolving threat landscape.
Manufactured in the US to the highest standards, our Veralize test device sensitivity is comparable to the gold standard, RT-PCR, and has clinically shown 98% accuracy. Veralize provides test results in under 7 minutes.
The Veralize system is designed to identify a wide range of cancers and infectious diseases by encoding our proprietary nanotube sensors with appropriate genetic detection information.
As biodefense challenges evolve from sporadic incidents to persistent threats, healthcare professionals and individuals alike will increasingly demand assurance that their concerns about potential biological threats are promptly and accurately addressed. Various parties involved in healthcare and public safety will seek robust solutions to ensure swift and precise identification of these threats, enabling effective response measures and safeguarding public health and security.